| Pharmaceutical active ingredients: |
| Benzoxonium ChlorideLidocaine Hydrochloride |
| Available forms, composition and doses of Mebucaliquid: |
| Solution; Local Oral; Benzoxonium Chloride 5 mg; Lidocaine Hydrochloride 5 mg / 10 ml |
| Mebucaliquid medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R02AA20 - Antiseptics, various |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mebucain | Cetylpyridinium Chloride; Oxybuprocaine Hydrochloride; Tyrothricin | Novartis |
| Mebucaine | Cetylpyridinium Chloride; Oxybuprocaine Hydrochloride; Tyrothricin | Novartis |
| Mebucaine F | Cetylpyridinium Chloride; Oxybuprocaine Hydrochloride; Tyrothricin | Novartis |
| Mebucalets F | Benzoxonium Chloride; Lidocaine | Novartis |
| Mebucalets F Gelsolets | Benzoxonium Chloride; Lidocaine | Novartis |
| Mebuca-Orange | Benzoxonium Chloride; Lidocaine Hydrochloride | Novartis |
| Mebucasol F | Lidocaine Hydrochloride; Lysozyme Hydrochloride; Tyrothricin | Novartis |
| Mebucaspray | Benzoxonium Chloride; Lidocaine Hydrochloride | Novartis |
| Mebumal | Pentobarbital | Unidentified Pharmaceutical Company |
| Mebutal | Butabarbital | Unidentified Pharmaceutical Company |